Dementia is a group of brain diseases that share similar symptoms, such as memory, language, orientation, and behavioral issues. Vascular dementia generally develops in the elderly, affecting between 1% and 4% of people over ...
Sep 4, 2023
0
49
A man-made antibody successfully prevented organ rejection when tested in primates that had undergone a kidney transplant, Duke Health researchers report.
Aug 30, 2023
0
80
More than 500 million people worldwide suffer from diabetes. Roughly 2.6 billion are overweight. Something that both groups have in common is that the hormone insulin does not work nearly as well for them as it does for people ...
Aug 30, 2023
0
27
Preeclampsia is a severe complication of pregnancy, affecting one in 40 pregnant women. Identifying high-risk patients is often difficult and complex because the exact cause of preeclampsia is still unknown.
Aug 29, 2023
0
14
Scientists of the Global Cardiovascular Risk Consortium under the auspices of the Department of Cardiology at the University Heart & Vascular Center of the Medical Center Hamburg-Eppendorf (UKE) and the German Center for ...
Aug 28, 2023
0
89
A new dementia risk score, which draws on 11 mostly modifiable risk factors, identifies people at risk—from midlife onward—of developing the disease within the next 14 years, suggests a large long term study published ...
Aug 25, 2023
0
57
Markers that indicate the presence of Parkinson's disease in patients on average seven years before clinical presentation have been identified by a UCL and Moorfields Eye Hospital research team.
Aug 21, 2023
0
338
Groundbreaking new research has uncovered a potential route to developing the first ever drug treatments for vascular dementia, that directly target a cause of the condition. The research, published in the Proceedings of ...
Aug 7, 2023
0
153
Researchers at the University of Illinois Chicago have identified a process by which enzymes can help prevent heart damage in chemotherapy patients.
Jul 20, 2023
0
71
A new drug could help lower persistent high blood pressure for up to six months following a single injection, a study suggests. If successful, the drug—zilebesiran—would provide a more convenient method for the management ...
Jul 20, 2023
0
22
